• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

（5,6-二甲基-1,10-菲咯啉）（2-{[2-（二苯基膦基）亚苄基]氨基}-乙胺）-铂（II）二硝酸酯甲醇溶剂化物

(5,6-Dimethyl-1,10-phenanthroline)(2-{[2-(di-phenyl-phosphan-yl)benzyl-idene]amino}-ethan-1-amine)-platinum(II) dinitrate methanol disolvate.

作者信息

Jurisinec Ashley, Zhang Yingjie, Aldrich-Wright Janice R

机构信息

School of Science, Western Sydney University, Locked Bag 1797, Penrith South DC, Sydney, NSW 2751, Australia.

Australian Nuclear Science and Technology Organisation, Kirrawee DC, New South Wales, Australia.

出版信息

Acta Crystallogr E Crystallogr Commun. 2025 Mar 4;81(Pt 4):275-278. doi: 10.1107/S2056989025001847. eCollection 2025 Apr 1.

DOI:10.1107/S2056989025001847
PMID:40201005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11974327/
Abstract

The title compound, Pt(CHN)(CHNP)·2CHOH, is a platinum(II) complex, which crystallizes in a monoclinic (2/) space group. The complex exhibits a distorted square-planar geometry, which includes a monodentate 5,6-dimethyl-1,10-phenanthroline ligand and a tridentate 2-{[2-(di-phenyl-phosphan-yl)benzyl-idene]amino}-ethan-1-amine ligand. The structure reveals both intra- and inter-molecular π-stacking inter-actions between the phenanthroline and phosphine rings. Hydrogen bonding is observed between the complex ion, nitrate counter-ions and solvent mol-ecules.

摘要

标题化合物Pt(CHN)(CHNP)·2CHOH是一种铂(II)配合物，其晶体属于单斜晶系（2/）空间群。该配合物呈现出扭曲的平面正方形几何构型，其中包括一个单齿的5,6-二甲基-1,10-菲咯啉配体和一个三齿的2-{[2-(二苯基膦基)亚苄基]氨基}乙胺配体。结构揭示了菲咯啉环和膦环之间存在分子内和分子间的π-堆积相互作用。在配合物离子、硝酸根抗衡离子和溶剂分子之间观察到了氢键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19fc/11974327/a933fa223ed2/e-81-00275-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19fc/11974327/5b539be65566/e-81-00275-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19fc/11974327/e1e92278e029/e-81-00275-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19fc/11974327/a933fa223ed2/e-81-00275-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19fc/11974327/5b539be65566/e-81-00275-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19fc/11974327/e1e92278e029/e-81-00275-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19fc/11974327/a933fa223ed2/e-81-00275-fig3.jpg

相似文献

1
(5,6-Dimethyl-1,10-phenanthroline)(2-{[2-(di-phenyl-phosphan-yl)benzyl-idene]amino}-ethan-1-amine)-platinum(II) dinitrate methanol disolvate.（5,6-二甲基-1,10-菲咯啉）（2-{[2-（二苯基膦基）亚苄基]氨基}-乙胺）-铂（II）二硝酸酯甲醇溶剂化物
Acta Crystallogr E Crystallogr Commun. 2025 Mar 4;81(Pt 4):275-278. doi: 10.1107/S2056989025001847. eCollection 2025 Apr 1.
2
Crystal structure and Hirshfeld surface analysis of (μ-2-{4-[(carboxyl-atometh-yl)carbamo-yl]benz-amido}-acetato-κ :')bis-[bis-(1,10-phenanthroline-κ ,')copper(II)] dinitrate ,'-(1,4-phenyl-enedicarbon-yl)diglycine monosolvate octa-hydrate.（μ-2-{4-[(羧基-原子甲基)氨基甲酰基]苯甲酰胺基}-乙酸根-κO:')双-[双-(1,10-菲咯啉-κN:')铜(II)]二硝酸酯，'-（1,4-苯二甲酰基）二甘氨酸单溶剂合物八水合物的晶体结构和 Hirshfeld 表面分析
Acta Crystallogr E Crystallogr Commun. 2019 Apr 25;75(Pt 5):667-674. doi: 10.1107/S2056989019005164. eCollection 2019 May 1.
3
Dichlorido{N-[2-(diphenyl-phosphan-yl)benzyl-idene]-2-(thio-phen-2-yl)ethan-amine-κP,N}platinum(II) dichloro-methane hemisolvate.二氯{N-[2-(二苯基膦基)亚苄基]-2-(噻吩-2-基)乙胺-κP,N}铂(II) 二氯甲烷半溶剂化物
Acta Crystallogr Sect E Struct Rep Online. 2012 Feb 1;68(Pt 2):m116-7. doi: 10.1107/S1600536811056108. Epub 2012 Jan 7.
4
Crystal structure of -[1,2-bis-(di-phenyl-phosphan-yl)ethene-κ,']di-chlorido-platinum(II) chloro-form disolvate: a new polymorph.- [1,2-双（二苯基膦基）乙烯-κ，']二氯铂（II）氯仿溶剂化物的晶体结构：一种新的多晶型物。
Acta Crystallogr E Crystallogr Commun. 2018 Jun 21;74(Pt 7):998-1001. doi: 10.1107/S2056989018008836. eCollection 2018 Jul 1.
5
Syntheses and crystal structures of [Ir{C(CHCOEt)(dppm)-κ ,,','}ClH]Cl·2.75CHCl and its derivatives, [Ir{C(CHCOEt)(dppm)-κ ,,','}(CHCOEt)Cl]Cl·CHOH·0.5HO, [Ir{C(CHCOEt)(dppm)-κ ,,','}Cl]Cl·CHOH·2HO and [Ir{C(CHCOEt)(dppm)-κ ,,','}(CHCOEt)(CO)]Cl·2CHCl·1.5HO.[Ir{C(CHCOEt)(dppm)-κ ,,','}ClH]Cl·2.75CHCl及其衍生物[Ir{C(CHCOEt)(dppm)-κ ,,','}(CHCOEt)Cl]Cl·CHOH·0.5HO、[Ir{C(CHCOEt)(dppm)-κ ,,','}Cl]Cl·CHOH·2HO和[Ir{C(CHCOEt)(dppm)-κ ,,','}(CHCOEt)(CO)]Cl·2CHCl·1.5HO的合成与晶体结构
Acta Crystallogr E Crystallogr Commun. 2019 Jan 1;75(Pt 1):12-20. doi: 10.1107/S2056989018017024.
6
Crystal structures of di-chlorido-palladium(II), -platinum(II) and -rhodium(III) complexes containing 8-(di-phenyl-phosphan-yl)quinoline.含8-（二苯基膦基）喹啉的二氯钯（II）、二氯铂（II）和三氯铑（III）配合物的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 Apr 2;71(Pt 5):447-51. doi: 10.1107/S2056989015006076. eCollection 2015 May 1.
7
Crystal structures of ()-(ethene-1,2-di-yl)bis-(di-phenyl-phosphine sulfide) and its complex with Pt dichloride.（）-（乙烯-1,2-二基）双（二苯基膦硫化物）及其与二氯化铂配合物的晶体结构。
Acta Crystallogr E Crystallogr Commun. 2023 Jan 1;79(Pt 1):28-32. doi: 10.1107/S2056989022011847.
8
Bis[N,N-bis-(diphenyl-phosphan-yl)pentyl-amine-κP,P']platinum(II) bis-(hexa-fluoridophosphate) dichloro-methane disolvate.双[N,N-双-(二苯基膦基)戊基-胺-κP,P']铂(II)双(六氟磷酸酯)二氯甲烷溶剂合物
Acta Crystallogr Sect E Struct Rep Online. 2010 Jul 14;66(Pt 8):m922-3. doi: 10.1107/S1600536810025560.
9
Crystal structure of bis-{'-[()-4-hy-droxy-benzyl-idene]pyridine-4-carbohydrazide-κ}di-iodidocadmium methanol disolvate.双-{'-[()-4-羟基苄叉基]吡啶-4-碳酰肼-κ}二碘化镉甲醇溶剂化物的晶体结构
Acta Crystallogr E Crystallogr Commun. 2017 Jan 1;73(Pt 1):28-30. doi: 10.1107/S2056989016019575.
10
Dichlorido{N-[2-(diphenyl-phosphan-yl)benzyl-idene]isopropyl-amine-κN,P}palladium(II) dimethyl sulfoxide monosolvate.二氯{N-[2-(二苯基膦基)亚苄基]异丙胺-κN,P}钯(II) 二甲亚砜单溶剂合物
Acta Crystallogr Sect E Struct Rep Online. 2011 May 1;67(Pt 5):m608-9. doi: 10.1107/S1600536811013936. Epub 2011 Apr 16.

本文引用的文献

1
Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity.具有强大抗癌活性的环氧化酶抑制铂（IV）前药
Pharmaceutics. 2022 Apr 3;14(4):787. doi: 10.3390/pharmaceutics14040787.
2
validation ALERTS: what they mean and how to respond.验证警报：其含义及应对方法
Acta Crystallogr E Crystallogr Commun. 2020 Jan 1;76(Pt 1):1-11. doi: 10.1107/S2056989019016244.
3
The Cambridge Structural Database.剑桥结构数据库。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016 Apr;72(Pt 2):171-9. doi: 10.1107/S2052520616003954. Epub 2016 Apr 1.
4
Comparison of silver and molybdenum microfocus X-ray sources for single-crystal structure determination.用于单晶结构测定的银和钼微焦点X射线源的比较。
J Appl Crystallogr. 2015 Jan 30;48(Pt 1):3-10. doi: 10.1107/S1600576714022985. eCollection 2015 Feb 1.
5
MX1: a bending-magnet crystallography beamline serving both chemical and macromolecular crystallography communities at the Australian Synchrotron.MX1：一条弯铁晶体学光束线，服务于澳大利亚同步加速器的化学和大分子晶体学研究群体。
J Synchrotron Radiat. 2015 Jan;22(1):187-90. doi: 10.1107/S1600577514021717. Epub 2015 Jan 1.
6
Integration, scaling, space-group assignment and post-refinement.整合、缩放、空间群确定及后续精修。
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):133-44. doi: 10.1107/S0907444909047374. Epub 2010 Jan 22.
7
The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators.辅助配体手性和菲咯啉官能团取代对铂（II）基金属嵌入剂细胞毒性的影响。
J Inorg Biochem. 2007 Jul;101(7):1049-58. doi: 10.1016/j.jinorgbio.2007.04.009. Epub 2007 May 4.
8
DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines.一些含有甲基取代的1,10-菲咯啉的铂（II）插入化合物的DNA结合及生物活性
Dalton Trans. 2004 Apr 21(8):1145-52. doi: 10.1039/b316511f. Epub 2004 Mar 19.
9
Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines.Blu-Ice与分布式控制系统：用于大分子晶体学光束线数据采集和仪器控制的软件。
J Synchrotron Radiat. 2002 Nov 1;9(Pt 6):401-6. doi: 10.1107/s0909049502015170.
10
Steric Crowding and Redox Reactivity in Platinum(II) and Platinum(IV) Complexes Containing Substituted 1,10-Phenanthrolines.含取代1,10-菲咯啉的铂（II）和铂（IV）配合物中的空间拥挤和氧化还原反应活性
Inorg Chem. 1996 May 22;35(11):3173-3182. doi: 10.1021/ic960125y.